hexamethonium has been researched along with Mononeuropathies in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Mononeuropathies: Disease or trauma involving a single peripheral nerve in isolation, or out of proportion to evidence of diffuse peripheral nerve dysfunction. Mononeuropathy multiplex refers to a condition characterized by multiple isolated nerve injuries. Mononeuropathies may result from a wide variety of causes, including ISCHEMIA; traumatic injury; compression; CONNECTIVE TISSUE DISEASES; CUMULATIVE TRAUMA DISORDERS; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rueter, LE | 1 |
| Kohlhaas, KL | 1 |
| Curzon, P | 1 |
| Surowy, CS | 1 |
| Meyer, MD | 1 |
1 other study available for hexamethonium and Mononeuropathies
| Article | Year |
|---|---|
Peripheral and central sites of action for A-85380 in the spinal nerve ligation model of neuropathic pain.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Chlorisondamine; Disease Models, Animal; Dose-Respons | 2003 |